Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             18 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper Gagelmann, Nico

9 10 p. e786-e795
artikel
2 An early glimpse at azacitidine plus venetoclax for myelodysplastic syndromes Pleyer, Lisa

9 10 p. e714-e716
artikel
3 A survey on the patient perspective on cure in multiple myeloma Mohyuddin, Ghulam Rehman

9 10 p. e716-e719
artikel
4 Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study Bazinet, Alexandre

9 10 p. e756-e765
artikel
5 Caregivers—an undervalued and underused essential The Lancet Haematology,

9 10 p. e707
artikel
6 CD19 CAR T cells for infants and young children Shalabi, Haneen

9 10 p. e712-e714
artikel
7 Faecal microbiota transplantation in patients with haematological malignancies undergoing cellular therapies: from translational research to routine clinical practice Malard, Florent

9 10 p. e776-e785
artikel
8 Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial Taher, Ali T

9 10 p. e733-e744
artikel
9 Luspatercept in patients with non-transfusion dependent β-thalassaemia Platzbecker, Uwe

9 10 p. e709-e711
artikel
10 Mitapivat for treatment of pyruvate kinase deficiency Costa, Fernando F

9 10 p. e708-e709
artikel
11 Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial Glenthøj, Andreas

9 10 p. e724-e732
artikel
12 Monika Asnani — addressing the unmet needs of sickle cell disease Cavanaugh, Ray

9 10 p. e721
artikel
13 Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG): a multicentre, open-label, phase 2 trial Cramer, Paula

9 10 p. e745-e755
artikel
14 Should patients with haemophilia receive gene therapy? VandenDriessche, Thierry

9 10 p. e722-e723
artikel
15 The evolving multi-agent options for chronic lymphocytic leukaemia treatment de la Serna, Javier

9 10 p. e711-e712
artikel
16 The underrepresented majority León, Andrés Gómez-De

9 10 p. e720
artikel
17 Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study Ghorashian, Sara

9 10 p. e766-e775
artikel
18 Venetoclax activity in a patient with central nervous system involvement by chronic lymphocytic leukaemia Soumerai, Jacob D

9 10 p. e796
artikel
                             18 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland
Toegankelijkheidsverklaring